Transplant & Cellular Therapy Program

illustration of stem cells and DNA helixIn collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, the Transplant and Cellular Therapy Program at Rutgers Cancer Institute has been performing autologous and allogeneic stem cell transplants since 1995. Ours is the only such program in New Jersey offered at an NCI-designated Comprehensive Cancer Center. 

The program treats patients with a number of illnesses including acute and chronic leukemias, myelodysplasia, lymphomas, Hodgkin disease, multiple myeloma, amyloidosis, and others. Our oncologists are experts in Blood and Marrow Transplants (BMT), CAR T-Cell therapy, cellular therapy and more.

The clinical and research interests of our clinicians focus on novel strategies to prevent graft-versus-host disease, improve umbilical cord blood transplants, and develop cellular therapies that are less toxic than standard transplants.

The Transplant and Cellular Therapy Program is accredited by the National Marrow Donor Program and the Foundation for the Accreditation of Cellular Therapy (FACT). It has been rated “Excellent” by the American College of Surgeons. We offer a full suite of oncology support services through which Oncology Nurse Navigators and transplant coordinators guide patients through treatment and beyond. Rutgers Cancer Institute also offers stem cell transplantation for children, adolescents and young adults with cancers and blood disorders through our Pediatric Stem Cell Transplantation and Cellular Therapies Program.

To request an appointment, call 844-CANCERNJ | Find Cellular Therapy Clinical Trials.

Your Transplant and Cellular Therapy Team

East TowerEast Tower

The Transplant and Cellular Therapy Program location: 

Learn more about the East Tower Location


Related News